Ligne de temps

Sylvain Baize
Responsable de Structure
30 sept. 2023
publication

Novel Antiviral Molecules against Ebola Virus Infection.

Lire plus
12 sept. 2023
publication

Hemostasis defects underlying the hemorrhagic syndrome caused by Mammarenaviruses in a cynomolgus macaque model.

Lire plus
11 mars 2023
publication

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys

Lire plus
01 janv. 2023
publication

A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates.

Lire plus
01 déc. 2022
publication

Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys.

Lire plus
21 mars 2022
publication

Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus.

Lire plus
09 juin 2021
publication

A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.

Lire plus
04 janv. 2021
publication

Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.

Lire plus
02 oct. 2019
publication

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot.

Lire plus
10 janv. 2019
publication

Immune parameters and outcomes during Ebola virus disease

Lire plus
27 juil. 2015
nrc

Fièvres Hémorragiques Virales

Lire plus
21 juil. 2015
publication

Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement

Lire plus
19 juil. 2015
publication

Towards deep insight into Ebola virus disease

Lire plus
03 juil. 2015
project

Lassa fever

Lire plus
11 mai 2015
team

Biologie des infections virales émergentes

Lire plus
06 févr. 2015
publication

Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus

Lire plus
01 janv. 2015
publication

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Lire plus
24 nov. 2014
publication

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014

Lire plus
19 nov. 2014
publication

Ebola: should we consider influenza vaccination?

Lire plus
24 sept. 2014
publication

Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response

Lire plus
24 sept. 2014
publication

The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

Lire plus
16 avr. 2014
publication

Emergence of Zaire Ebola virus disease in Guinea

Lire plus
27 févr. 2014
publication

Anjozorobe hantavirus, a new genetic variant of Thailand virus detected in rodents from Madagascar

Lire plus
09 janv. 2014
publication

Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever

Lire plus
25 avr. 2013
publication

Severe Seoul hantavirus infection in a pregnant woman, France, October 2012

Lire plus
05 nov. 2012
publication

Immune responses and Lassa virus infection

Lire plus
31 août 2011
publication

Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages

Lire plus
01 juil. 2011
publication

Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa

Lire plus
01 oct. 2010
publication

Towards broad protection against Ebolaviruses

Lire plus
20 mars 2006
publication

Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages

Lire plus
01 oct. 2004
publication

Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection

Lire plus